{"entity":{"id":"nanoecho","kind":"company","name":"NanoEcho","aka":["NanoEcho AB"],"tldr":"NanoEcho was developing a way to see whether rectal cancer had spread to nearby lymph nodes, using iron oxide particles that vibrate in a magnetic field and show up on ultrasound. The company was declared bankrupt in October 2026.","summary":"NanoEcho AB (publ), of Lund, Sweden, developed a diagnostic method combining iron oxide-based nanoparticles, a magnetic field and ultrasound imaging to map whether early rectal cancer has spread to nearby lymph nodes, with the aim of sparing patients unnecessary major surgery. Its phase 2 study (NCT06693375) evaluated dose and safety of NanoEcho Particle-1 with the NanoEcho imaging device in healthy volunteers and rectal cancer patients, under EU trial number 2024-515335-29-00. On 12 October 2026 the Helsingborg District Court declared the company bankrupt and appointed a trustee. Its first registered cancer study, NCT06693375, was posted on ClinicalTrials.gov in November 2024.","asOf":"2026-10-29","links":[{"label":"Official website","url":"https://nanoecho.se/en/"},{"label":"Bankruptcy announcement, 12 October 2026 (Swedish)","url":"https://nanoecho.se/mfn_news/nanoecho-ab-publ-har-forsatts-i-konkurs/"}],"tags":[],"related":[],"cancers":["rectal-cancer"],"sections":["imaging","diagnostics"],"technologies":["ultrasound"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct06693375"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Bankruptcy is from the company's own release of 12 October 2026 (in Swedish), read on 29 October 2026.","Founding year not stated on the pages read.","Study results were not read; the study's status in the registry may not yet reflect the bankruptcy."],"hq":"Lund","country":"SE","companyType":"imaging","website":"https://nanoecho.se/en/","stage":"defunct","investors":[],"funding":[]},"route":"/companies/nanoecho/","neighbours":{"cancer":[{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"section":[{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"},{"id":"imaging","kind":"section","name":"Imaging","route":"/fronts/imaging/"}],"technology":[{"id":"ultrasound","kind":"technology","name":"Ultrasound","route":"/technologies/ultrasound/"}],"trial":[{"id":"nct06693375","kind":"trial","name":"To Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer Patients.","route":"/trials/nct06693375/"}]}}